Aspirin harmful in women

In what will be a stunning study for allopathic medicine (but not to us), a December 28th European Heart Journal study wanted to identify women who benefit from aspirin 100 mg on alternate days for primary prevention of vascular events by using treatment effect prediction based on individual patient characteristics.

Data from the Women's Health Study were used to predict treatment effects for 27,939 women in terms of absolute risk reduction for major cardiovascular events (i.e. myocardial infarction, stroke, or cardiovascular death) over a ten year period.

Aspirin was ineffective or even harmful in the majority of patients. Age was positively related to treatment effect, whereas current smoking and baseline risk for cardiovascular events were not. The aspirin treatment strategy that is associated with optimal net benefit in primary prevention of vascular events in women is to treat none.

AMD an Issue With Aspirin As Well
In a second study, the risks for early age-related macular degeneration (AMD) are associated with frequent aspirin use, and the risk increases with greater aspirin consumption, European researchers reported in an article published in the January 2012 issue of Ophthalmology.